However, only 5–10% of patients with early-onset Alzheimer’s disease are carrying a pathogenic mutation in APP, PSEN1, PSEN2, or the common apolipoprotein E (APOE) ɛ4 allele (See Figure 4) [5]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.